Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate‐Supplementation for Cell Therapy against StrokeChengbo Tan(Hokkaido University), Kiyohiro Houkin(Hokkaido University)Stem Cells InternationalJanuary 1, 201610.1155/2016/6104780Cited by 22SaveCiteExport RISWatch citationsRelated PapersDual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial|The Lancet Neurology|2019|216